Could vitamin B3 help save sight in rare eye disease?
NCT ID NCT06007391
First seen Apr 06, 2026 · Last updated Apr 28, 2026 · Updated 5 times
Summary
This study tests whether vitamin B3 (nicotinamide) is safe and helpful for people with dominant optic atrophy, a genetic condition that slowly damages the optic nerve and leads to vision loss. Researchers will give the vitamin to 25 adults with the disease and monitor for side effects and any improvement in eye function. The goal is to see if this simple supplement can protect the optic nerve and slow down vision loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NICOTINAMIDE ADVERSE REACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Angers University Hospital
Angers, France
Conditions
Explore the condition pages connected to this study.